The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Launch of Indian public health standards for Ayush healthcare facilities
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Sustainability is integral to Biocon's business purpose
The restructuring aims to create synergies across the business and strengthen capital structure
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
_256_384.png){kind=logo}
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
Subscribe To Our Newsletter & Stay Updated
